Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.015
+0.005 (0.25%)
Jun 23, 2026, 1:29 PM EDT - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $48.21 million as of June 23, 2026. Its market cap has decreased by -72.58% in one year.
Market Cap
48.21M
Enterprise Value
40.44M
1-Year Change
-72.58%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $48.21M, a decrease of -68.31%. That is a compound annual growth rate of -46.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 48.21M | -66.11% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 54.15M |
| PDS Biotechnology | 53.30M |
| Xilio Therapeutics | 52.59M |
| Dogwood Therapeutics | 52.13M |
| Instil Bio | 50.86M |
| Radiopharm Theranostics | 49.70M |
| Mereo BioPharma Group | 49.39M |
| Hyperion DeFi | 49.01M |